The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease

Expert Review of Neurotherapeutics
Byron CreeseClive Ballard

Abstract

Antipsychotics have long been the mainstay of treatment for agitation and psychosis in Alzheimer's disease. Despite their current use successive studies have shown that they only confer a modest benefit which must be balanced against their well-established serious side effects (extrapyramidal symptoms, stroke, accelerated cognitive decline and mortality). Areas covered: This review outlines the current guidance on antipsychotic usage and the evidence of their continued usage against a backdrop of emerging pharmacological treatments and an increasing emphasis on the importance of non-pharmacological interventions. Expert commentary: The current justification for antipsychotic use in the context of the changing landscape of prescribing and provide a view on the most promising alternative candidates to this class of drug are appraised.

References

Jun 1, 1991·Archives of Neurology·G S ZubenkoU Kopp
Jan 1, 1996·Journal of the American Geriatrics Society·B W RovnerM F Folstein
Jan 1, 1997·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·D L SultzerM E Mahler
Jan 20, 1998·The American Journal of Psychiatry·P N TariotC Irvine
Nov 23, 2000·Neurology·L TeriUNKNOWN Alzheimer's Disease Cooperative Study
Dec 12, 2001·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·J T OlinL S Schneider
Sep 24, 2002·JAMA : the Journal of the American Medical Association·Constantine G LyketsosSteven DeKosky
Apr 3, 2003·International Psychogeriatrics·Serge GauthierUNKNOWN Donepezil MSAD Study Investigators Group
Oct 23, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M Garcia-AllozaM J Ramírez
Jan 27, 2006·The Cochrane Database of Systematic Reviews·C Ballard, J Waite
Mar 1, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Lon S SchneiderPhilip S Insel
Mar 8, 2006·Psychopharmacology·Sebastian WaltherDieter Kunz
May 23, 2006·Nature Reviews. Neuroscience·Clive Ballard, Robert Howard
Jun 15, 2007·Zeitschrift für Gerontologie und Geriatrie·R Mahlberg, S Walther
Oct 5, 2007·The New England Journal of Medicine·Robert J HowardUNKNOWN CALM-AD Trial Group
Dec 18, 2007·International Journal of Geriatric Psychiatry·Michael J Passmore
Aug 2, 2008·Brain : a Journal of Neurology·Peita D BruenAnnalena Venneri
Feb 3, 2009·Dementia and Geriatric Cognitive Disorders·Oskar H SommerKnut Engedal
Feb 3, 2009·Neuropsychiatric Disease and Treatment·Sibel Cakir, Isin Baral Kulaksizoglu
Sep 29, 2009·International Psychogeriatrics·Patricia A WilkoszRobert A Sweet
Mar 3, 2011·Journal of Clinical Psychopharmacology·Sebastian WaltherWerner Strik
Aug 4, 2011·Archives of General Psychiatry·Pierre N TariotUNKNOWN Alzheimer's Disease Cooperative Study Group
Apr 20, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Matthew R WoodwardJames M Ellison
Oct 10, 2013·Biological Psychiatry·Patrick S MurrayRobert A Sweet
Feb 20, 2014·JAMA : the Journal of the American Medical Association·Anton P PorsteinssonUNKNOWN CitAD Research Group
Mar 13, 2015·Journal of Neurology·Rowena Carter, Dominic H Ffytche
Sep 24, 2015·JAMA : the Journal of the American Medical Association·Jeffrey L CummingsJoão Siffert
Oct 21, 2015·Dementia and Geriatric Cognitive Disorders Extra·Jon N WergelandØyvind Kirkevold

❮ Previous
Next ❯

Citations

Apr 11, 2019·International Psychogeriatrics·Alys W GriffithsClaire A Surr
Mar 9, 2019·Israel Journal of Health Policy Research·Pauline Lorey
Oct 24, 2019·Translational Psychiatry·Byron CreeseUNKNOWN AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative
Jan 11, 2020·Frontiers in Pharmacology·Valeria CalsolaroFabio Monzani
Aug 31, 2020·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Yasaman MalekizadehByron Creese
Jul 10, 2019·Expert Review of Neurotherapeutics·Valeria CalsolaroFabio Monzani
Feb 3, 2020·Neurobiology of Aging·Ehsan PishvaKatie Lunnon
May 4, 2021·Frontiers in Neurology·Claudia CarrariniLaura Bonanni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Paediatrics & Child Health
Tamara PringsheimCanadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guideline group
Current Opinion in Psychiatry
Clive Ballard, Anne Corbett
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Juleen Rodakowski, Elizabeth R Skidmore
© 2022 Meta ULC. All rights reserved